IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RIMOLDI, ISABELLA SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.226
EU - Europa 9.100
AS - Asia 8.601
SA - Sud America 841
AF - Africa 187
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 6
Totale 28.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.912
SG - Singapore 2.687
CN - Cina 2.555
IT - Italia 2.248
GB - Regno Unito 2.205
DE - Germania 1.011
SE - Svezia 866
HK - Hong Kong 729
RU - Federazione Russa 679
BR - Brasile 629
VN - Vietnam 615
IN - India 549
FR - Francia 440
IE - Irlanda 309
BD - Bangladesh 277
KR - Corea 258
FI - Finlandia 244
NL - Olanda 242
TR - Turchia 196
JP - Giappone 195
CA - Canada 194
DK - Danimarca 170
ID - Indonesia 167
ES - Italia 161
UA - Ucraina 122
PL - Polonia 65
CH - Svizzera 60
CO - Colombia 59
AT - Austria 57
MX - Messico 57
CI - Costa d'Avorio 53
BE - Belgio 52
PK - Pakistan 52
AR - Argentina 47
IR - Iran 45
AU - Australia 43
EU - Europa 40
TW - Taiwan 40
PH - Filippine 37
ZA - Sudafrica 33
IQ - Iraq 31
CL - Cile 30
GR - Grecia 29
CZ - Repubblica Ceca 27
EC - Ecuador 25
MY - Malesia 24
MA - Marocco 21
RO - Romania 21
VE - Venezuela 21
IL - Israele 20
SA - Arabia Saudita 19
UZ - Uzbekistan 18
DZ - Algeria 16
TH - Thailandia 16
EG - Egitto 15
CR - Costa Rica 14
AZ - Azerbaigian 13
SC - Seychelles 13
JM - Giamaica 12
PT - Portogallo 12
AL - Albania 11
NZ - Nuova Zelanda 11
PE - Perù 11
LT - Lituania 10
NO - Norvegia 10
BG - Bulgaria 9
HU - Ungheria 9
NP - Nepal 9
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
JO - Giordania 6
PA - Panama 6
TN - Tunisia 6
HN - Honduras 5
KE - Kenya 5
LU - Lussemburgo 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
UY - Uruguay 5
BZ - Belize 4
GT - Guatemala 4
HR - Croazia 4
LB - Libano 4
LV - Lettonia 4
NG - Nigeria 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
CM - Camerun 3
EE - Estonia 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
MV - Maldive 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
Totale 28.010
Salva come PNG Salva come JPEG
Città #
Southend 1.907
Singapore 1.596
Dallas 973
Ashburn 922
Milan 826
Hong Kong 595
Chandler 563
San Jose 543
Beijing 443
Fairfield 416
Council Bluffs 348
Seattle 333
Wilmington 279
Dublin 276
Hefei 256
Ann Arbor 253
Los Angeles 252
Princeton 241
Frankfurt am Main 238
Houston 225
Woodbridge 213
Santa Clara 212
Ho Chi Minh City 197
Bengaluru 188
Cambridge 180
New York 173
Munich 167
Hanoi 151
Lauterbourg 139
Helsinki 137
Moscow 125
Jakarta 121
Nanjing 115
Guangzhou 111
Seoul 111
Buffalo 102
Tokyo 101
Phoenix 83
Bologna 82
Boardman 81
Dearborn 81
Des Moines 80
Toronto 77
Jacksonville 74
Shanghai 64
Mountain View 63
Columbus 61
Redmond 59
Redwood City 59
Medford 55
São Paulo 55
Rome 54
Abidjan 53
Berlin 53
Istanbul 52
Cangzhou 45
Padova 45
Shenzhen 45
Brussels 44
Hangzhou 44
Naples 44
The Dalles 44
Jinan 43
Andover 41
Bogotá 41
Changsha 41
Nuremberg 40
Tianjin 38
Shenyang 37
Chicago 36
Kent 36
Orem 36
Florence 35
Kolkata 35
London 35
San Diego 34
Karlsruhe 33
Roxbury 33
Somerville 33
Serra 31
Turin 31
Da Nang 30
Sakarya 30
Zhengzhou 30
Brescia 29
Nanchang 29
Warsaw 29
Bergamo 28
Lappeenranta 28
Rio de Janeiro 28
Vienna 28
Amsterdam 27
Atlanta 27
Haiphong 27
Boston 26
Fremont 26
Turku 26
Wuhan 26
Montreal 25
Saint Petersburg 24
Totale 16.737
Salva come PNG Salva come JPEG
Nome #
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 421
Amphiphilic Pt(II) complexes for in vivo bioimaging applications 418
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 414
Artificial metalloenzymes based on vancomycin for stereoselective catalysis in aqueous media 367
1,4-bis-difosfino-(Z)-2-buteni, 1,4 disostituiti otticamente puri in qualità di leganti chirali per la catalisi omogenea stereocontrollata con metalli di transizione 338
Cytotoxic effect of (1-methyl-1H-imidazol-2-yl)-methanamine and its derivatives in PtII complexes on human carcinoma cell lines: A comparative study with cisplatin 315
Luminescent amphiphilic Pt(II) complexes and their assemblies 298
Efficient methodology to produce a duloxetine precursor using whole cells of Rhodotorula rubra 297
Self-assembly in vivo: imaging and reactivity 294
Simple 1,3-diamines and their application as ligands in ruthenium(ii) catalysts for asymmetric transfer hydrogenation of aryl ketones 292
Conventional and non-conventional catalytic systems for the asymmetric reduction of cyclic imines 287
VCD spectroscopy as an excellent probe of chiral metal complexes containing a carbon monoxide vibrational chromophore 287
Fluorinated dichloride platinum complexes: a new series of promising anticancer agents against orphan tumors 286
Sensitivity of mesenchymal stromal cells to a new imidazole-based cationic Pt(II) complex with high in vitro anticancer activity 283
Novel 3,3-disubstituted oxindole derivatives. Synthesis and evaluation of the anti-proliferative activity 279
Water soluble Ir-complexes for ECL signal amplification in pathogens detection 278
Ruthenium(II) complexes bearing (NNN) ligand : catalytic evaluation of different solvent-mediated coordination modes 277
Self-assembled complex promotes cell proliferation and stem cell self-renewal through redox signaling in in vivo model 276
Novel platinum agents and mesenchymal stromal cells for thoracic malignancies : state of the art and future perspectives 273
Antiproliferative effects of chalcones on T cell acute lymphoblastic leukemia‐derived cells: Role of PKCβ 272
Monofunctional Pt(II) complexes based on 8-aminoquinoline: synthesis and pharmacological characterization 268
Cascade Reaction by Chemo- and Biocatalytic Approaches to Obtain Chiral Hydroxy Ketones and anti 1,3-Diols 267
A tandem MS precursor-ion scan approsch to identify variable covalent modification of albumin Cys34 : a new tool for studyng vascular carbonylation 266
“In situ” Activation of Racemic RuII Complexes: Separation of trans and cis Species and Their Application in Asymmetric Reduction 263
Electrochemiluminescent multinuclear metal complexes for diagnostics 257
Anticancer platinum(II) complexes bearing N-heterocycle rings 256
Exploring the copper binding ability of Mets7 hCtr‐1 protein domain and His7 derivative: An insight in Michael addition catalysis 254
Chiral 1,4-bis-diphosphine ligands from optically active (Z)-olefines 249
Alternative Strategy to Obtain Artificial Imine Reductase by Exploiting Vancomycin/D-Ala-D-Ala Interactions with an Iridium Metal Complex 248
Malignant Pleural Mesothelioma : State of the art and advanced cell therapy 246
Cytotoxic platinum(II) complexes bearing N-heterocycle rings as novel theranostic agents 245
Enantioselective transfer hydrogenation of aryl ketones: synthesis and 2D-NMR characterization of new 8-amino-5,6,7,8-tetrahydroquinoline Ru(II)-complexes 244
Vancomycin-Iridium (III) Interaction: An Unexplored Route for Enantioselective Imine Reduction 244
Uptake-release by MSCs of a cationic platinum(II) complex active in vitro on human malignant cancer cell lines 242
Luminescent self-assemblies of Pt(II) complexes in vivo 242
Catalytic Applications for Heavy Metals Bio-recovery 238
Evaluation of chemical diversity of biotinylated chiral 1,3-diamines as a catalytic moiety in artificial imine reductase 237
Anticancer platinum‑drug delivered by mesenchymal stromal cells improves its activity on glioblastoma 236
Luminescent water-soluble cycloplatinated complexes: structural, photophysical, electrochemical and chiroptical properties 231
Synthesis and crystallographic structure of nickel(0) carbonyl complex with Bitianp, an atropoisomeric diphosphine 231
Enhancing Pt (IV) Complexes Anticancer Activity Upon Encapsulation in Stimuli Responsive Nanocages 229
One-pot catalytic strategies for the efficient and enantioselective synthesis of L-Carnosine 229
In vitro anticancer activity evaluation of new cationic platinum(II) complexes based on imidazole moiety 227
8-Amino-5,6,7,8-tetrahydroquinoline in iridium(iii) biotinylated Cp* complex as artificial imine reductase 226
Cationic platinum(II) complexes active in vivo as anticancer drugs 222
Promising antiproliferative platinum(II) complexes based on imidazole moiety: synthesis, evaluation in HCT-116 cancer cell line and interaction with Ctr-1 Met-rich domain 220
Chiral 1,4-diphosphines, 1,4-diphosphites and 1,4-diphosphonites from optically active (Z)-olefins as ligands for metal-catalyzed asymmetric hydrogenation and hydroformylation reactions 218
3-(Hydroxy(phenyl)methyl)azetidin-2-ones obtained via catalytic asymmetric hydrogenation or by biotransformation 217
Asymmetric reductions of ethyl 2-(benzamidomethyl)-3-oxobutanoate by yeasts 216
8-Amino-5,6,7,8-Tetrahydroquinolines as Ligands in Iridium(III) Catalysts for the Reduction of Aryl Ketones by asymmetric transfer hydrogenation (ATH) 216
Analisi farmaceutica 215
Stereoselective synthesis of 1-methylcarbapenem precursors : studies on the diastereoselective hydroformylation of 4-vinyl b-lactam with aminophosphonite–phosphinite and aminophosphine–phosphite rhodium(I) complexes 214
Asymmetric reduction by transition metals complexes and biocatalysts 213
Cationic Pt(II) complex based on 8-aminoquinoline: in vitro activity against human glioblastoma 213
catalisi enantioselettiva : sintesi di istidina non naturale e istidina non naturale deuterata 210
Asymmetric Hydrogenation of prochiral Ketones catalyzed by Ru(II)Cl2diphosphine/diamine system 210
Aminophosphonite-phosphite and aminophosphonite-phosphinite ligands with mixed chirality: preparation and catalytic applications in asymmetric hydrogenation and hydroformylation 210
8-Amino-5,6,7,8-tetrahydroquinolines as ligands in iridium(III) catalysts for the reduction of aryl ketones by asymmetric transfer hydrogenation (ATH) 207
Structural variations on chiral ligands : new chelating diphosphines from optically active (1,4)-(Z)-2-butenes 206
DIOPHEP, a chiral diastereoisomer bisphosphine ligands : synthesis and applications in asymmetric hydrogenations 204
Ni²⁺ and Cu²⁺ Biosorption by EPS-Producing Serratia plymuthica Strains and Potential Bio-Catalysis of the Organo–Metal Complexes 203
The mesenchymal stromal cells increased the activity on glioblastoma of a new delivered anticancer platinum-drug 201
On the relation between carbonyl stretching frequencies and the donor power of chelating diphosphines in nickel dicarbonyl complexes 199
Mesenchymal stromal cells for antineoplastic drug loading and delivery 198
One-pot reactions in catalysis: a valuable tool for the synthesis of enantiopure intermediates for pharmaceutical applications 192
Vibrational circular dichroism and chiroptical properties of chiral Ir(III) luminescent complexes 192
Hybrid Catalysts from Copper Biosorbing Bacterial Strains and Their Recycling for Catalytic Application in the Asymmetric Addition Reaction of B2(pin)2 on α,β-Unsaturated Chalcones 192
Hystidine and deuterium labelled hystidine by catalytic reduction with Rh(I)-diphosphine complexes and non coordinating strong acids. 189
Chemo- and biocatalytic strategies to obtain phenylisoserine, lateral chain of taxol by asymmetric reduction 187
Diastereoselectivity and catalytic activity in ruthenium complexes chiral at the metal centre 186
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase‑B 186
Combined chemical and biocatalytic approach for asymmetric one-pot reactions 183
Amphiphilic Pt(II) complex for in vivo imaging applications 183
New chiral ligands for the enantioselective catalysis with transition metal complexes 183
Mets7 motif peptides in coordinative Cu(I) complexes: application in asymmetric Henry reaction 183
New sp3 diphosphine-based rhodium catalysts for the asymmetric conjugate addition of aryl boronic acids to 3-azaarylpropenones 182
difosfine chelanti innovative e loro applicazioni in catalisi asimmetrica. 180
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 180
STAT3 direct inhibitors: from MD77 to AC33 180
New Mets7 motif metallopeptide catalysts for Cu(I)-catalyzed asymmetric Henry reaction 180
In Vitro Activity of Monofunctional Pt-II Complex Based on 8-Aminoquinoline against Human Glioblastoma 180
Aminoquinoline-based Ruthenium catalyst for reduction of ketones by hydrogen transfer 178
Highly efficient morpholine-based organocatalysts for the 1,4-addition reaction between aldehydes and nitroolefins: an unexploited class of catalysts 177
Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam 174
"In situ" activation of racemic Ru(II) complexes : separation of trans and cis species and their application in asymmetric reduction 174
Luminescent chiral ionic Ir(III) complexes : synthesis and photophysical properties 174
Asymmetric Hydrogenation of 1-aryl substituted-3,4-Dihydroisoquinolines with Iridium Catalysts Bearing Different Phosphorus-Based Ligands 173
Histidine and deuterium labelled histidine by asymmetric catalytic reduction with gaseous H-2 or D-2 : the role of strong non-coordinating acids 172
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 172
Synthesis and anticancer activity of cyclometalated Pt(II) neutral complexes containing curcumin as a bioactive ancillary ligand 170
Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds 169
Recycling of copper contaminants from wastewater as new hybrid catalysts for the synthesis of valuable pharmaceutical intermediates 164
Chiral Aminophosphonite-phosphite and Aminophosphonite-phosphinite Ligands in Asymmetric Hydroformylation of Carbapenem Antibiotics Precursors. 164
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 164
A new series of fluorinated dichloride platinum complexes as promising anticancer agents against orphan tumors 163
Histidine and deuterium-labelled histidine by asymmetric catalytic reduction and assignment of the absolute stereochemistry by neutron diffraction 162
Alizarin as a selective carrier in cytotoxic Pt(II) complexes toward Triple Negative Breast Cancer (TNBC) 161
A new artificial reductase based on the D-Ala-D-Ala/Vancomycin supramolecular interaction and its applications in the enantioselective reduction of cyclic imines 160
Cytotoxic performances of new anionic cyclometalated Pt(II) complexes bearing chelated O^O ligands 160
Equilibri ionici 1. : acidi e basi 158
Totale 22.666
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021301 0 0 0 0 0 0 0 0 0 0 189 112
2021/20222.356 211 97 85 140 187 161 192 134 308 157 194 490
2022/20232.568 341 253 237 207 259 400 76 191 258 62 185 99
2023/20241.829 77 148 112 111 316 104 139 164 48 132 232 246
2024/20254.723 188 425 212 474 399 273 260 431 266 398 481 916
2025/202610.589 994 845 1.630 939 1.059 723 1.349 487 1.051 660 852 0
Totale 29.229